TYR and Alzheimer disease: Compared with existing blood biomarkers for AD classification (e.g., plasma ATN biomarkers, plasma p-tau181, and p-tau217), the combination of these 19 protein markers demonstrated superior accuracy, achieving an AUC of up to 0.98.